A clinical study to learn about effect of naval retention therapy in condition of diarrhoea predominant irritable bowel syndrome

Effect of nabhi vasthi in diarrhoea predominant irritable bowel syndrome-A clinical study - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104320

Enrollment

Registered

2026-02-19

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K580- Irritable bowel syndrome with diarrhea

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Increased bowel frequency _Rome 4 criteria Bowel form-loose stool Previously diagnosed case. Following diet 1 month before study

Exclusion criteria

Exclusion criteria: Candidates who have administered antibiotics or probiotics for greater than or equal to one month prior to the time of sample collection Skin lesion or local infections in and around umbilical area. Inflammatory Bowel Disease Pregnant and lactating women Underwent surgery for umbilical hernia, laparotomy. Rectal bleeding Having sensitivity to ginger

Design outcomes

Primary

Measure	Time frame
1)Changes in symptoms of IBS-D using IBS-Symptoms Severity Score. Timepoint: 0th day,8th day and 22nd day	—

Secondary

Measure	Time frame
2) Modulations in gut microbiome will be assessed before first day(0th )of basthi and next day (8th day) after last basti (in sub samples) using 16S rRNA.Timepoint: 0th day and 8th day;3)Improvement in stool form and frequency using Bristol stool scale.Timepoint: 0th day,8th day,22nd day	—

Countries

India

Contacts

Public ContactDr Simi Ravindran

Government Ayurveda Medical College and Hospital Pullimoodu junction Thiruvananthapuram

nihlausmanpk@gmail.com9447392139

Outcome results